We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-14.51%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.25B
AUM Growth
-$409M
Cap. Flow
-$106M
Cap. Flow %
-8.49%
Top 10 Hldgs %
50.14%
Holding
212
New
40
Increased
31
Reduced
43
Closed
54

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$43.5M
2
RGNX icon
Regenxbio
RGNX
+$19.9M
3
ARAV
Aravive, Inc. Common Stock
ARAV
+$15.6M
4
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
+$14.2M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.7M

Top Sells

Rank Stock Value
1
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$19M
2
AGN
Allergan plc
AGN
+$18M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$17.5M
4
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$17M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 80.82%
2 Miscellaneous 18.47%
3 Consumer Staples 0.59%
4 Consumer Discretionary 0.07%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
176
Pacira BioSciences
PCRX
$960M
– –
-50
Closed -$4K
RGLS
177
PUT
DELISTED
Regulus Therapeutics
RGLS
– –
-1,667
Closed -$2.2M
SGMO
178
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-800,000
Closed -$8.87M
SSO icon
179
ProShares Ultra S&P500
SSO
$8.76B
– –
-240,000
Closed -$1.87M
SUPN icon
180
Supernus Pharmaceuticals
SUPN
$2.4B
– –
-19,470
Closed -$331K
THC icon
181
Tenet Healthcare
THC
$21B
– –
-8,500
Closed -$492K
TVTX icon
182
PUT
Travere Therapeutics
TVTX
$5.89B
– –
-100,000
Closed -$3.31M
UHS icon
183
Universal Health Services
UHS
$10.4B
– –
-1,883
Closed -$268K
UNH icon
184
UnitedHealth
UNH
$337B
– –
-1,685
Closed -$206K
VTRS icon
185
Viatris
VTRS
$19.1B
– –
-215,133
Closed -$14.6M
ZBH icon
186
Zimmer Biomet
ZBH
$18.8B
– –
-139,249
Closed -$14.8M
TCON
187
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-500
Closed -$1.29M
ABMD
188
DELISTED
Abiomed Inc
ABMD
– –
-10,000
Closed -$657K
RDUS
189
DELISTED
Radius Health, Inc.
RDUS
– –
-235,530
Closed -$15.9M
EPZM
190
DELISTED
Epizyme, Inc
EPZM
– –
-60,000
Closed -$1.44M
XENT
191
DELISTED
Intersect ENT, Inc
XENT
– –
-10,251
Closed -$293K
EVFM
192
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
– –
-222
Closed -$180K
IMMU
193
DELISTED
Immunomedics Inc
IMMU
– –
-600,000
Closed -$2.44M
IMMU
194
PUT
DELISTED
Immunomedics Inc
IMMU
– –
-700,000
Closed -$2.84M
TTPH
195
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-5,000
Closed -$4.74M
PTLA
196
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-111,103
Closed -$5.06M
AGN
197
DELISTED
Allergan plc
AGN
– –
-59,185
Closed -$18M
GNMX
198
DELISTED
Aevi Genomic Medicine Inc
GNMX
– –
-465,225
Closed -$2.85M
KERX
199
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-34,380
Closed -$343K
CBPO
200
DELISTED
China Biologic Products Holdings, Inc.
CBPO
– –
-147,604
Closed -$17M
5 6 7
8
9

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Perceptive Advisors held 212 positions worth $1.25B, down 25% from $1.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $106M in Q3 2015, closing 54 positions and reducing 43 holdings. Its most notable exit was ZS PHARMA INC COMS TK (DE), an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 82% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Global Blood Therapeutics, Inc. worth $38.9M.

  • Perceptive Advisors's largest Q3 2015 buy was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2015, an estimated $15.6M increase.
  • Perceptive Advisors's biggest Q3 2015 reduction was ANI Pharmaceuticals, cutting an estimated $17.5M.
  • Perceptive Advisors fully exited ZS PHARMA INC COMS TK (DE) in Q3 2015, selling an estimated $19M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.25B portfolio in Q3 2015.
  • Perceptive Advisors opened 40 new positions and closed 54 in Q3 2015.
  • Perceptive Advisors's portfolio value fell 25% quarter-over-quarter to $1.25B.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.